•  
  •  
  •  
  •  

2026-07-25 05:17:03

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • TANFAC Industries Reports Q1 FY27 Net Profit of ₹16.85 Crore; Operational Revenue Up 6.3% YoY to ₹187.18 Crore
  • New India Assurance Reports Q1 FY27 Net Loss of ₹243.94 Crore; Gross Written Premium Rises 2.9% YoY to ₹13,835 Crore
  • NTPC Consolidated Q1 FY27 Net Profit Rises 12.9% YoY to ₹6,896 Crore; Operational Revenue Up 7.8% at ₹50,741 Crore
  • Neogen Chemicals Reports Q1 FY27 Net Profit Surge of 66.8% YoY to ₹17.11 Crore; Operational Revenue Up 34% at ₹250.29 Crore
  • Arihant Capital Markets Reports Q1 FY27 Net Profit of ₹21.49 Crore, Up 69.2% YoY; Operational Revenue Jumps 53.5%

Keywords Selected:  FermentaBiotech

Stock Report

  • Fermenta Biotech Ltd receives FSSAI nod for its product Vitamin D3 (Cholecalciferol) - Plant Source
  • Fermenta ranked among India's Best Workplaces™ in Pharmaceuticals, Healthcare & Biotech by Great Place to Work®
  • Fermenta Board approves INR 110 Crore Capex at Dahej for Plant-based Vitamin D3, Green Chemistry Enzyme, and Vitamin D3 Derivatives
  • Fermenta Biotech Limited Certified as a Great Place to Work®
  • Fermenta Board approves sale of Environmental Solutions Business to Wholly Owned Subsidiary
  • Fermenta Granted Process Patent for Plant-Based Vitamin D3
  • Fermenta announces Granting of CEP by EDQM for VITADEE™ 100 SD, Enabling Accelerated Global Growth
  • Fermenta Signs Strategic MoU with NIFTEM-T to Strengthen India's Food Fortification Landscape
  • Fermenta enters its 75th Year, Celebrating a Legacy Built on Trust
  • Fermenta's Plant-based Vitamin D3 is 'Innovation of the Year'
  • Manali Petrochemicals Limited enters into MoU with Fermenta Biotech Ltd
  • Fermenta Biotech Ltd's API manufacturing facility receives certificate of EU GMP compliance
  • Fermenta Biotech Limited receives EIR from USFDA for Dahej manufacturing facility
  • Fermenta Biotech Ltd executes sale deed for land sale
  • Fermenta Biotech Ltd posts Rs. 1.83 crore PAT in Q1FY24
  • Fermenta Biotech Limited recommends final dividend of Rs. 1.25
  • Fermenta Biotech Ltd posts consolidated loss of Rs. 3.74 crore in Q4FY23
  • Fermenta Biotech Ltd sells property of Rs. 11.33 crores
  • Fermenta Biotech Ltd sinks to Q3FY23 consolidated loss of Rs. 37.39 crores
  • Fermenta Biotech Ltd executes sale deed to sell premises at Thane One Building
  • Fermenta Biotech Limited executes sale deed for property sale
  • Fermenta Biotech Ltd Q1 FY2023 consolidated loss at Rs. 2.30 crore
  • Fermenta Biotech extends validity period of binding term sheet for real estate development
  • Fermenta Biotech Q3FY22 consolidated loss at Rs. 8.04 crores

Latest Post

  • TANFAC Industries Reports Q1 FY27 Net Profit of ₹16.85 Crore; Operational Revenue Up 6.3% YoY to ₹187.18 Crore
  • New India Assurance Reports Q1 FY27 Net Loss of ₹243.94 Crore; Gross Written Premium Rises 2.9% YoY to ₹13,835 Crore
  • NTPC Consolidated Q1 FY27 Net Profit Rises 12.9% YoY to ₹6,896 Crore; Operational Revenue Up 7.8% at ₹50,741 Crore
  • Neogen Chemicals Reports Q1 FY27 Net Profit Surge of 66.8% YoY to ₹17.11 Crore; Operational Revenue Up 34% at ₹250.29 Crore
  • Arihant Capital Markets Reports Q1 FY27 Net Profit of ₹21.49 Crore, Up 69.2% YoY; Operational Revenue Jumps 53.5%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025